Related Experiment Video
Updated: Sep 6, 2025

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents
Published on: August 10, 2018
Circulating miRNAs in progressive supranuclear palsy: Recent evidence and future challenges
Ida Manna1, Selene De Benedittis2, Andrea Quattrone2
1Institute of Molecular Bioimaging and Physiology (IBFM), National Research Council (CNR), Section of Germaneto, 88100, Catanzaro, Italy.
Abstract:
Numerous studies have highlighted the importance of microRNA (miRNAs) in neurodegenerative diseases. However, the miRNA profiles in progressive supranuclear palsy (PSP) patients have been rarely reported. Recent evidence suggested a possible role of some dysregulated miRNAs in the cerebrospinal fluid (CSF) of PSP patients in the pathogenesis of the disease.
More Related Videos
10:37Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
Related Concept Videos
MicroRNAs
Neural Regulation